biotech · Dental Caries · Cystic Fibrosis · ARMP
Armata Pharmaceuticals
Armata Pharmaceuticals is a biotech organization headquartered in Freehold, USA. It trades on NYSE under ticker ARMP. Primary therapeutic focus areas include Dental Caries, Cystic Fibrosis, Non-cystic Fibrosis Bronchiect
Freehold, USA HQ
2018 Founded
18 Employees
Public company Type
ARMP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Freehold, USA
- Founded
- 2018
- Employees
- 18
- Programs
- 9
- Drugs
- 0
- Patents
- 5
AP-PA02
Phase 2 · mab · Non-cystic Fibrosis Bronchiectasis
AP-PA02 for Non-cystic Fibrosis Bronchiectasis is a Phase 2 program (mab) at Armata Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code AP-PA02-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Armata Pharmaceuticals
- Phase
- Phase 2
- Modality
- mab
- Indication
- Non-cystic Fibrosis Bronchiectasis
- Status
- completed
- Trials
- 1